TLTFF News Alert Theralase Technologi (TLTFF) 0.5753 12/16/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Theralase Technologi (TLTFF) 0.5753 $TLTFF

Brian C. Wilson Joins Theralase Medical and Scientific Advisory Board
ACCESSWIRE - Tue Dec 16, 6:07AM CST
Toronto, Ontario / ACCESSWIRE / December 16, 2014 / Theralase Technologies Inc. ("Theralase" (TLT:TSXV) (TLTFF: OTC Pink(R)) announced today that Brian C. Wilson, PhD has agreed to join the Theralase Medical and Scientific Advisory Board ("MSAB" .
TLT.VN: 0.630 (-0.010)

University of Toledo Validates University Health Network In-Vitro Data
TheNewswire.ca - Tue Dec 09, 6:05AM CST
(via Thenewswire.ca)
TLT.VN: 0.630 (-0.010)

Dr. Michael A. O'Donnell Joins Theralase Medical and Scientific Advisory Board
ACCESSWIRE - Wed Dec 03, 6:07AM CST
Toronto, Ontario / ACCESSWIRE / December 3, 2014 / Theralase Technologies Inc. ("Theralase" (TLT:TSXV) (TLTFF: OTC Link(R)) announced today that Michael A. O'Donnell, MD, Professor of Urology, University of Iowa located in Iowa City, Iowa has agreed to join the Theralase Medical and Scientific Advisory Board ("MSAB" .
TLT.VN: 0.630 (-0.010)

Dr. Ashish M. Kamat Joins Theralase Medical and Scientific Advisory Board
TheNewswire.ca - Tue Dec 02, 10:36AM CST
(via Thenewswire.ca)
TLT.VN: 0.630 (-0.010)

Theralase Releases 3Q2014 Financials
ACCESSWIRE - Fri Nov 28, 7:43AM CST
Toronto, Ontario / ACCESSWIRE / November 28, 2014 / Theralase Technologies Inc. ("Theralase" (TLT: TSXV) (TLTFF: OTC Link(R)) released its third quarter 2014 financial results today, demonstrating a decrease in revenue for the three month period ended September 30, 2014 of 57% and a decrease in revenue of 15% for the nine month period ended September 30, 2014, while making dramatic progress in both its patented next generation Therapeutic Laser Technology ("TLT" division and its Photo Dynamic Therapy ("PDT" anti-cancer division.
TLT.VN: 0.630 (-0.010)

Theralase Releases Annual General Meeting Video
ACCESSWIRE - Tue Nov 25, 6:06AM CST
Toronto, Ontario / ACCESSWIRE / November 25, 2014 / Theralase Technologies Inc. ("Theralase" (TSXV: TLT) (TLTFF: OTCBB) announced today that it has released a video of the presentations conducted at the Theralase 2013 Annual General Meeting ("AGM" , held on November 14, 2014. The presentations were conducted by Theralase President and CEO, Roger Dumoulin-White and Dr. Lothar Lilge, Professor in the Department of Medical Biophysics University of Toronto and Senior Scientist, Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network ("UHN" .
TLT.VN: 0.630 (-0.010)

Theralase Further Validates Anti-Cancer Memory Response
ACCESSWIRE - Mon Nov 17, 9:55AM CST
Toronto, Ontario / ACCESSWIRE / November 17, 2014 / Theralase Technologies Inc. ("Theralase" (TSXV: TLT) (TLTFF: OTCBB) announced today that in new preclinical research, conducted at Princess Margaret Cancer Centre, University Health Network ("UHN" , that it has further validated its Photo Dynamic Compound's ("PDCs" ability to destroy a primary host tumour and even more importantly render the animal immune to a repeated exposure of the same cancer.
TLT.VN: 0.630 (-0.010)

Theralase Presents Latest Research on Destruction of Cancer and Bacteria at International Conference
ACCESSWIRE - Thu Oct 16, 6:09AM CDT
Toronto, Ontario - October 16, 2014 -Theralase Technologies Inc. ("Theralase(R)" (TSXV: TLT) (TLTFF: OTC Link(R)) announced today that it has presented its latest research on the success of its Photo Dynamic Compounds ("PDCs" in the destruction of cancer and bacteria. This research was presented at the 10th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, taking place in Brixen, Italy from October 14 to 18, 2014.
TLT.VN: 0.630 (-0.010)

Theralase Partners with SAFC in Manufacture of Anti-Cancer Drugs
ACCESSWIRE - Tue Oct 07, 6:08AM CDT
Toronto, Ontario / ACCESSWIRE / October 7, 2014 / Theralase Technologies Inc. ("Theralase(R)" (TSXV: TLT) (TLTFF: OTC Link(R)) announced today that it has collaborated with Sigma-Aldrich Corporation's (NASDAQ: SIAL) custom manufacturing services business unit SAFC(R) Commercial , in the manufacture of the Photo Dynamic Compounds ("PDCs" being developed by Theralase for the destruction of cancer.
SIAL: 136.10 (+0.19), TLT.VN: 0.630 (-0.010)

Theralase Files Voluntary Annual Information Form
ACCESSWIRE - Wed Sep 24, 6:01AM CDT
Toronto, Ontario / ACCESSWIRE / September 24, 2014 / Theralase Technologies Inc. ("Theralase(R)" (TSXV: TLT) (TLTFF: OTC Link(R)) announced today that it has filed a voluntary Annual Information Form ("AIF" as part of its corporate strategy to become eligible for the registration of a base shelf prospectus as this term is defined in National Instruments 44-101 Short Form Prospectus Distributions and 44-102 Shelf Distributions.
TLT.VN: 0.630 (-0.010)

Theralase Partners with Montreal's JSS Medical Research to Bring Innovative Bladder Cancer Treatment to Market
ACCESSWIRE - Thu Sep 11, 6:01AM CDT
Toronto, Ontario / ACCESSWIRE / September 11, 2014 / To take advantage of the vastly improved business climate in Quebec, Theralase Technologies Inc. ("Theralase" (TSXV: TLT) (TLTFF: OTC Link(R)) announced today that it is partnering with JSS Medical Research Inc. ("JSS" , a Montreal based Contract Research Organization ("CRO" , to consult and provide guidance in the completion of a FDA / Health Canada Phase I/IIa clinical study. The clinical study planned for early 2015 will evaluate the safety and efficacy of Theralase's innovative Photo Dynamic Therapy ("PDT" platform in the destruction of bladder cancer. Theralase anticipates executing further agreements in the Quebec biotech sector worth several million dollars over the next 12 to 18 months.
TLT.VN: 0.630 (-0.010)

Theralase Launches Multi Wavelength Laser for Cancer Destruction
ACCESSWIRE - Tue Sep 09, 6:04AM CDT
Toronto, Ontario / ACCESSWIRE / September 9, 2014 / Theralase Technologies Inc. ("Theralase" (TSXV: TLT) (TLTFF: OTC Link(R)) announced today that it has successfully launched its TLC-3000 multi wavelength laser system capable of activating its patented and patent pending Photo Dynamic Compounds (PDCs) for the destruction of cancer in an preclinical environment. This is the first commercial system on the market capable of effectively activating a 96 well plate of cancer cells with wavelengths in the visible to Near Infrared (NIR) spectrum using programmable energy levels. Intellectual protection for this system was recently applied for under a pending US patent.
TLT.VN: 0.630 (-0.010)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 67

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
Cedars-Sinai and nference Build a Living Data Engine

Updated Category News Views 175

Five million patient histories are not a flashy product demo. They are a serious raw-material advantage, provided the data can be protected, organized, and made useful without turning clinical research into a carnival of loose claims. That is the real weight behind nference's long-term collaboration with Cedars-Sinai, announced November 20, 2026. The pair plan to build a...

Continue Reading
California Stone Ban Puts a Hidden Worker Toll in View

Updated Category News Views 42

Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....

Continue Reading
Appian Survey Flags AI Aloneware Maintenance Drag Risk

Updated Category News Views 58

A bot can spit out a feature before lunch, then leave a repair bill nobody budgeted for. That is the uncomfortable issue behind Appian's new research on AI-assisted software development: speed is easy to celebrate, while ownership gets shoved into a dark corner until something breaks. Appian said on November 20, 2026, that two-thirds of surveyed AI decision-makers and IT...

Continue Reading
Tigo's Guidance Gap Draws Lawsuit and Investor Scrutiny

Updated Category News Views 84

A Revenue Promise Hit the Wall Solar investing can turn ugly in a hurry when a supposedly near-term catalyst gets shoved down the calendar. That is the central bruise behind the securities class action involving Tigo Energy, not some arcane accounting footnote that only lawyers can love. The complaint alleges Tigo overstated the revenue contribution it expected from its...

Continue Reading
Perigon Builds Its Investment Bench for the Next Leg

Updated Category News Views 110

Perigon is rearranging the engine room before the next growth spurt gets noisy. The firm has named Christopher Broderick Director of Investments and Research, added two trading associates, and put another brick behind the broader operating structure Rafia Hasan has been assembling since taking on the chief operating officer role in August. That may sound like ordinary...

Continue Reading
1031 Specialists Takes Tax Deferral to Public TV

Updated Category News Views 100

A tax rule most people ignore is getting a television spotlight. 1031 Specialists says it will appear on All Access with Andy Garcia, an educational series distributed to Public Television stations nationwide, to explain the 1031 exchange and its role in real estate investing. That is a sensible bit of exposure for a niche business built around a topic investors tend to...

Continue Reading
Sleep Number’s Couples Pitch Has Some Fine Print Too

Updated Category News Views 75

A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 39

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 71

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading

Top 5 Most Recently Viewed Articles

Constellation Brands Innovates with New Wine Portfolio Focus

Updated Category News Views 254

Constellation Brands Completes Transaction with The Wine Group ROCHESTER, N.Y. — Constellation Brands (NYSE: STZ), a prominent player in the beverage alcohol industry, has officially finalized its transaction with The Wine Group, marking a significant shift in its wine strategy. By divesting mainstream wine brands and associated assets, Constellation aims to concentrate...

Continue Reading
GomSpace North America Secures Major USD 1.5 Million Order

Updated Category News Views 198

Exciting Order Announcement from GomSpace North America GomSpace North America, a subsidiary of GomSpace Group AB, has successfully secured a major order valued at USD 1.5 million. This contract, which underscores the growing trust in GomSpace's advanced technological solutions, involves supplying key components aimed at supporting an upcoming satellite mission. Details...

Continue Reading
Venice Comprehensive Dentistry's Evolution: A New Era of Care

Updated Category News Views 169

Venice Comprehensive Dentistry's Transformation Venice Comprehensive Dentistry, previously known as Florida Dental Implant Center, has officially announced a significant rebranding aimed at better reflecting the diverse range of dental services it now offers. This exciting change marks a pivotal moment in the practice's journey, emphasizing its commitment to comprehensive...

Continue Reading
Important Insights from ABC Arbitrage's Upcoming General Meeting

Updated Category News Views 183

Understanding ABC Arbitrage's General Meeting ABC arbitrage is gearing up for a significant event as it prepares for its upcoming Combined General Meeting. Scheduled at a centrally located venue, this meeting promises to provide shareholders with essential insights into the company’s direction. Meeting Details and Important Dates The Combined General Meeting of ABC...

Continue Reading
Arrowpoint Investment Partners Selects SS&C for Fund Services

Updated Category News Views 291

Arrowpoint Investment Partners Chooses SS&C for Fund Management Arrowpoint Investment Partners, a newly established multi-strategy hedge fund investment firm, has made a significant move in the evolving financial services landscape by selecting SS&C GlobeOp for the administration of its flagship investment fund, valued at $1 billion. This decision highlights the firm’s...

Continue Reading